Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer.
about
A novel BRCA2 mutation in an Indonesian family found with a new, rapid, and sensitive mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing.High penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series.Germline PTEN mutations are rare and highly penetrantTowards evidence-based management of inherited breast and breast-ovarian cancer.The relation between projected breast cancer risk, perceived cancer risk, and mammography use. Results from the National Health Interview Survey.Risk assessment and management of high risk familial breast cancer.Does perceived risk predict breast cancer screening use? Findings from a prospective cohort study of female relatives from the Ontario site of the breast cancer family registryTumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography.Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality.Accuracy of Self-Reported Screening Mammography Use: Examining Recall among Female Relatives from the Ontario Site of the Breast Cancer Family Registry.The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation.Intrusion and avoidance in subjects undergoing genetic investigation and counseling for hereditary cancer.Estimated prevalence of hereditary cancers and the need for surveillance in a Norwegian county, Telemark.The BRCA2 variant c.68-7 T>A is associated with breast cancer.Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds.Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.Identification of genetic variants for clinical management of familial colorectal tumors.The relationship between psychological distress and personality in women from families with familial breast/ovarian or hereditary non-polyposis colorectal cancer in the absence of demonstrated mutations.Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancer.The relationship between coping strategies and anxiety in women from families with familial breast-ovarian cancer in the absence of demonstrated mutations.Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry.Quality of life and its relation to cancer-related stress in women of families with hereditary cancer without demonstrated mutation.Medical Myths and Legends: Presidential Address to the Ulster Medical Society. 6th October 2016.Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics,BRCAmutations and oophorectomy
P2860
Q33214483-C9FCC8AD-057F-47DA-96D8-F5846331CDB9Q33687533-774465ED-C5B1-4BD1-9239-1A138D15B866Q33722586-4FF6F16E-C54C-4A8A-99F9-26918BD21F68Q33732247-756E21A7-3678-433C-B32C-B3F0154B2E69Q34704139-9A20D744-E0A1-4340-9FD8-4998343AEB64Q35019822-F44D9DDA-7896-4858-83C9-8C5F94403945Q35049656-C8FE1CC7-058B-4E5B-94C7-F8EEC9624A2CQ35746459-9EB20EA5-9076-4317-80E9-4E4B451C5663Q36800313-D49A32E6-7325-48AA-B473-798C36C200C4Q37105163-1D3894BC-7C9E-4BC1-AA6B-EBECDCB7E208Q37656381-43F2E6CB-56D7-48BA-BAE6-4EEC58E07B1DQ40001844-234A6493-5DEB-4574-B50C-8C0FC9F42911Q44841081-D470EE16-DD2B-4C50-8808-7082B7172F88Q47153795-D993B3F3-1460-41E4-AAD2-F28FCF5E22D0Q47341959-AE02C5E4-C5F1-4320-B8F2-2F0F8F5085ECQ48162236-A9AC932B-B420-4FBE-A14D-3D865720799FQ48307169-F0227235-C2F3-4533-B616-2690CD53A8A5Q49844031-CBA5C55B-B644-45D0-BD7D-D17C7AB7930FQ50784937-3CDE9566-BEBE-4EF2-A3F6-E8247144D2E4Q50874684-A794BCEA-D4C8-4DFB-BAA2-9A195B6A5192Q50905946-C661C229-C9A9-4AC6-971F-E4CEC24788E8Q51196865-7FD54123-E1A6-48E3-AA32-3FFC5F2B74FAQ51814603-3AD86B55-DE8E-438E-A5CF-26947505F336Q55257859-41CD55A8-45AF-4519-A2A0-7C7896274046Q57266788-3369AD13-E42A-42C8-A279-E9147A8D2DC7
P2860
Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Guidelines for follow-up of wo ...... me on Inherited Breast Cancer.
@ast
Guidelines for follow-up of wo ...... me on Inherited Breast Cancer.
@en
type
label
Guidelines for follow-up of wo ...... me on Inherited Breast Cancer.
@ast
Guidelines for follow-up of wo ...... me on Inherited Breast Cancer.
@en
prefLabel
Guidelines for follow-up of wo ...... me on Inherited Breast Cancer.
@ast
Guidelines for follow-up of wo ...... me on Inherited Breast Cancer.
@en
P2093
P50
P356
P1433
P1476
Guidelines for follow-up of wo ...... me on Inherited Breast Cancer.
@en
P2093
E Anderson
G Bevilacqua
P304
P356
10.1155/1999/920109
P50
P577
1999-10-01T00:00:00Z